Patents by Inventor Simon Bailey

Simon Bailey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11977213
    Abstract: An imaging system may include a sample stage comprising a surface to support a sample container, the sample container including a sample having a plurality of sample locations; an optical stage to image the sample at the plurality of sample locations; one or more actuators physically coupled to at least one of the sample stage and the optical stage to move the sample stage relative to the optical stage to focus the optical stage onto a current sample location of the plurality of sample locations; a first light source to illuminate the current sample location; a second light source to project a pair of spots on a next sample location of the plurality of sample locations; and a controller to determine, based on an image of the pair of spots projected on the next sample location, a focus setting for the next sample location.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: May 7, 2024
    Assignee: ILLUMINA, INC.
    Inventors: Ashkan Arianpour, John Bailey, Dustin Blair, Xiangling (Steve) Chen, Stanley S. Hong, Simon Prince, Merek C. Siu, Chunhong (Allen) Zhou, Danilo Condello
  • Patent number: 11878968
    Abstract: Disclosed are compounds and salts thereof that bind to and modulate cereblon activity. In some embodiments, the binding and modulation of cereblon results in the degradation of IKAROS family zinc finger proteins (e.g., IKZF2).
    Type: Grant
    Filed: November 3, 2022
    Date of Patent: January 23, 2024
    Assignee: Plexium, Inc.
    Inventors: Pengyu Yang, Simon Bailey
  • Patent number: 11845770
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. For example, the present invention provides methods of treating immune and/or inflammatory disorders by administering a composition comprising a compound having the structure of Formula (I).
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: December 19, 2023
    Assignees: California Institute of Technology, Holoclara, Inc.
    Inventors: Brian M. Stoltz, Corey M. Reeves, Eduardo J. Martinez, Simon Bailey
  • Publication number: 20230304640
    Abstract: A solar light system may include a solar panel module adapted for converting solar light into electric power. The solar light system may include a splitter cable adapted for connecting electrically and mechanically to the solar panel module, the splitter cable comprising a main power cable connecting to the solar panel module, and at least two downstream cables coupled to the main power cable, each comprising a connection terminal adapted for connecting electrically and mechanically to a lighting device to be powered therethrough, wherein the connection terminals feature a securing part designed for interfacing with a coupling component into a weatherproof connection.
    Type: Application
    Filed: March 28, 2023
    Publication date: September 28, 2023
    Inventors: Simon BAILEY, Michael DAHAN
  • Publication number: 20230265071
    Abstract: Disclosed are compounds and salts thereof that bind to and modulate cereblon activity. In some embodiments, the binding and modulation of cereblon results in the degradation of IKAROS family zinc finger proteins (e.g., IKZF2).
    Type: Application
    Filed: November 3, 2022
    Publication date: August 24, 2023
    Inventors: Pengyu Yang, Simon Bailey
  • Publication number: 20230135574
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. For example, the present invention provides methods of treating immune and/or inflammatory disorders by administering a composition comprising a compound having the structure of Formula (I).
    Type: Application
    Filed: October 21, 2022
    Publication date: May 4, 2023
    Inventors: Brian M. Stoltz, Corey M. Reeves, Eduardo J. Martinez, Simon Bailey
  • Publication number: 20220409650
    Abstract: Described herein are composition of ascarosides, methods of using them, and the like for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for modifying a microbiome of a patient (e.g., for treatment of gut microbiome dysfunction).
    Type: Application
    Filed: June 3, 2020
    Publication date: December 29, 2022
    Inventors: Andrea Choe, Brian Stoltz, Simon Bailey, Eduardo Martinez
  • Publication number: 20220235086
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. For example, the present invention provides methods of treating immune and/or inflammatory disorders by administering a composition comprising a compound having the structure of Formula (I).
    Type: Application
    Filed: May 15, 2020
    Publication date: July 28, 2022
    Inventors: Brian M. Stoltz, Corey M. Reeves, Eduardo J. Martinez, Simon Bailey
  • Publication number: 20220204539
    Abstract: The present disclosure relates generally to compounds that are inhibitors of CD73 and are useful in treating CD73-associated diseases or conditions. Compositions containing the compounds of the present disclosure are also provided.
    Type: Application
    Filed: April 3, 2020
    Publication date: June 30, 2022
    Inventors: Simon BAILEY, Dianjun CHEN, Jianxia FENG, Frank KAYSER, Chong LIU, Hongbin YUAN
  • Publication number: 20220185832
    Abstract: Disclosed are compounds that arc inhibitors of CD73 and arc useful in treating CD73-associated diseases or conditions, and compositions containing the compounds.
    Type: Application
    Filed: April 3, 2020
    Publication date: June 16, 2022
    Inventors: Simon BAILEY, Dianjun CHEN, Jianxia FENG, Frank KAYSER, Chong LIU, Hongbin YUAN
  • Publication number: 20210274619
    Abstract: An exterior light operable with a remote comprises a light panel assembly, a motion detector for detecting movement in an area of the exterior light and a control panel comprising controls for selecting a mode of operation of the exterior light. The exterior light comprises a housing enclosing a battery powering the light panel assembly. Modes of operations of the exterior light comprise a time duration and conditions in which the battery is used to power the exterior light panel assembly upon the motion detector sensing movement. A remote control allows to override the mode of operation from the control panel for a given period.
    Type: Application
    Filed: February 23, 2021
    Publication date: September 2, 2021
    Inventors: Simon BAILEY, Michael DAHAN
  • Patent number: 10520177
    Abstract: A mounting adaptor for an electric light fixture to be mounted on a surface. The mounting adaptor comprising: a base and a joining member each having an interfacing face and an electrical interface, one of the base and the joining member comprising on its interfacing face a groove, the other one of the base and the joining member comprising on its interfacing face a lip adapted to cooperate with the groove thereby providing a capability to assemble releasably the joining member with the base; a locking mechanism adapted to lock the base and the joining member in a mounted position relatively to each other; the base comprising a mounting element adapted to mount the base to the surface; and the joining member comprising a joint element adapted to mount the electric light fixture to the joining member.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: December 31, 2019
    Assignee: LES PRODUITS SUNFORCE INC.
    Inventors: Simon Bailey, Michael Dahan, Leslie Wexelman
  • Patent number: 10168032
    Abstract: A mounting adaptor for an electric light fixture to be mounted on a surface. The mounting adaptor comprising: a base and a joining member each having an interfacing face, one of the base and the joining member comprising on its interfacing face a groove, the other one of the base and the joining member comprising on its interfacing face a lip adapted to cooperate with the groove thereby providing a capability to assemble releasably the joining member with the base; a locking mechanism adapted to lock the base and the joining member in a mounted position relatively to each other; the base comprising a mounting element adapted to mount the base to the surface; and the joining member comprising a joint element adapted to mount the electric light fixture to the joining member.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: January 1, 2019
    Inventors: Simon Bailey, Michael Dahan, Leslie Wexelman
  • Publication number: 20180195703
    Abstract: A mounting adaptor for an electric light fixture to be mounted on a surface. The mounting adaptor comprising: a base and a joining member each having an interfacing face and an electrical interface, one of the base and the joining member comprising on its interfacing face a groove, the other one of the base and the joining member comprising on its interfacing face a lip adapted to cooperate with the groove thereby providing a capability to assemble releasably the joining member with the base; a locking mechanism adapted to lock the base and the joining member in a mounted position relatively to each other; the base comprising a mounting element adapted to mount the base to the surface; and the joining member comprising a joint element adapted to mount the electric light fixture to the joining member.
    Type: Application
    Filed: March 6, 2018
    Publication date: July 12, 2018
    Inventors: Simon BAILEY, Michael DAHAN, Leslie WEXELMAN
  • Publication number: 20180156427
    Abstract: A mounting adaptor for an electric light fixture to be mounted on a surface. The mounting adaptor comprising: a base and a joining member each having an interfacing face, one of the base and the joining member comprising on its interfacing face a groove, the other one of the base and the joining member comprising on its interfacing face a lip adapted to cooperate with the groove thereby providing a capability to assemble releasably the joining member with the base; a locking mechanism adapted to lock the base and the joining member in a mounted position relatively to each other; the base comprising a mounting element adapted to mount the base to the surface; and the joining member comprising a joint element adapted to mount the electric light fixture to the joining member.
    Type: Application
    Filed: December 2, 2016
    Publication date: June 7, 2018
    Inventors: Simon BAILEY, Michael DAHAN, Leslie WEXELMAN
  • Patent number: 9133215
    Abstract: The invention relates to compounds of formula (?) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: September 15, 2015
    Assignee: Pfizer Inc.
    Inventors: Simon Bailey, Benjamin Joseph Burke, Michael Raymond Collins, Jingrong Jean Cui, Judith Gail Deal, Robert Louis Hoffman, Qinhua Huang, Ted William Johnson, Robert Steven Kania, John Charles Kath, Phuong Thi Quy Le, Michele Ann McTigue, Cynthia Louise Palmer, Paul Francis Richardson, Neal William Sach
  • Publication number: 20140135339
    Abstract: The invention relates to compounds of formula (?) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
    Type: Application
    Filed: January 15, 2014
    Publication date: May 15, 2014
    Applicant: PFIZER INC.
    Inventors: Simon Bailey, Benjamin Joseph Burke, Michael Raymond Collins, Jingrong Jean Cui, Judith Gail Deal, Robert Louis Hoffman, Qinhua Huang, Ted William Johnson, Robert Steven Kania, John Charles Kath, Phuong Thi Quy Le, Michele Ann McTigue, Cynthia Louise Palmer, Paul Francis Richardson, Neal William Sach
  • Patent number: 8680111
    Abstract: The invention relates to compounds of formula (?) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: March 25, 2014
    Assignee: Pfizer Inc.
    Inventors: Simon Bailey, Benjamin Joseph Burke, Michael Raymond Collins, Jingrong Jean Cui, Judith Gail Deal, Robert Louis Hoffman, Qinhua Huang, Ted William Johnson, Robert Steven Kania, John Charles Kath, Phuong Thi Quy Le, Michele Ann McTigue, Cynthia Louise Palmer, Paul Francis Richardson, Neal William Sach
  • Publication number: 20130252961
    Abstract: The invention relates to compounds of formula (?) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
    Type: Application
    Filed: March 5, 2013
    Publication date: September 26, 2013
    Applicant: PFIZER INC.
    Inventors: Simon BAILEY, Benjamin Joseph Burke, Michael Raymond Collins, Jingrong Jean Cui, Judith Gail Deal, Robert Louis Hoffman, Qinhua Huang, Ted William Johnson, Robert Steven Kania, John Charles Kath, Phuong Thi Quy Le, Michele Ann McTigue, Cynthia Louise Palmer, Paul Francis Richardson, Neal William Sach
  • Patent number: D1007554
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: December 12, 2023
    Assignee: Optima Low Vision Services Ltd.
    Inventors: John Collins, Nicholas Collins, Austen Miller, Simon Bailey